Screener
Phathom Pharmaceuticals, Inc. PHAT Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Operating right-of-use assets and lease liabilities | 5 | 66 |
| Inventory | (3,291) | (14,178) |
| Other long-term assets | (171) | — |
| Net cash used in operating activities | (17,577) | (147,659) |
| Cash flows from investing activities | ||
| Cash paid for property and equipment | (105) | (115) |
| Net cash used in investing activities | (105) | (115) |
| Cash flows from financing activities |
Item 1. Financial Statements (unaudited)
FAQ
- What is Phathom Pharmaceuticals, Inc.'s operating cash flow?
- Phathom Pharmaceuticals, Inc. (PHAT) reported operating cash flow of -$1.93M in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s operating cash flow changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s operating cash flow increased by 96.9% year-over-year, from -$62.73M to -$1.93M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s operating cash flow has grown at a 2.9% compound annual growth rate (CAGR), from -$148.62M to -$166.78M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Phathom Pharmaceuticals, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude